AMERIGROUP (NYSE: AGP) is one of 15 public companies in the “Hospitals, Clinics & Primary Care Services” industry, but how does it contrast to its rivals? We will compare AMERIGROUP to related businesses based on the strength of its valuation, institutional ownership, analyst recommendations, earnings, profitability, risk and dividends.

Profitability

This table compares AMERIGROUP and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
AMERIGROUP N/A N/A N/A
AMERIGROUP Competitors 4.89% -0.38% 4.48%

Analyst Ratings

This is a breakdown of current ratings and price targets for AMERIGROUP and its rivals, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AMERIGROUP 0 0 0 0 N/A
AMERIGROUP Competitors 57 326 509 9 2.52

As a group, “Hospitals, Clinics & Primary Care Services” companies have a potential upside of 23.93%. Given AMERIGROUP’s rivals higher probable upside, analysts clearly believe AMERIGROUP has less favorable growth aspects than its rivals.

Institutional & Insider Ownership

69.5% of shares of all “Hospitals, Clinics & Primary Care Services” companies are owned by institutional investors. 10.8% of shares of all “Hospitals, Clinics & Primary Care Services” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Valuation & Earnings

This table compares AMERIGROUP and its rivals top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
AMERIGROUP N/A N/A 35.82
AMERIGROUP Competitors $1.06 billion -$22.56 million 736.87

AMERIGROUP’s rivals have higher revenue, but lower earnings than AMERIGROUP. AMERIGROUP is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Risk and Volatility

AMERIGROUP has a beta of 1.08, indicating that its stock price is 8% more volatile than the S&P 500. Comparatively, AMERIGROUP’s rivals have a beta of 0.72, indicating that their average stock price is 28% less volatile than the S&P 500.

Summary

AMERIGROUP rivals beat AMERIGROUP on 6 of the 8 factors compared.

AMERIGROUP Company Profile

AMERIGROUP Corporation is a multi-state managed healthcare company focused on serving people who receive healthcare benefits through publicly funded healthcare programs, including Medicaid, Children’s Health Insurance Program (CHIP), Medicaid expansion programs and Medicare Advantage. The Company offers a continuum of care management, including disease management, pharmacy integration, centralized telephonic case management, in-person case management within healthcare facilities, and home visit case management for some of its members. As of December 31, 2011, the Company provided a number of healthcare products to approximately 2,024,000 members. Effective February 1, 2012, it provides managed care services in Louisiana. On May 1, 2012, it acquired Health Plus. In November 2012, the Company sold its Virginia health plan to Inova Health System Foundation. In December 2012, WellPoint Inc acquired the Company.

Receive News & Ratings for AMERIGROUP Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMERIGROUP Co. and related companies with MarketBeat.com's FREE daily email newsletter.